|
 |
|
Fresenius Medical Care, the world's largest
provider of dialysis products and services,
has launched a new therapy programme for
peritoneal dialysis (PD). 'P3', the first
comprehensive PD care concept of its kind,
was introduced at the 9th European
Peritoneal Dialysis Meeting "EuroPD" in
Strasbourg, France this week.
In contrast to the mere provision of
individual products and services, 'P3' for
the first time provides PD therapy as an
integrated care programme, incorporating all
aspects of treatment, from the PD machine,
or "cycler", and related equipment to
special software and services for the
monitoring of treatment safety and quality.
With this holistic approach, 'P3' aims to
support physicians and nurses in adjusting
treatment even more closely to a patient's
individual needs - improving the overall
quality of PD therapy.
This aim is reflected in the programme's
name: 'P3' stands for 'Protect', 'Preserve'
and 'Prolong'. 'Protect' refers to Fresenius
Medical Care's portfolio of PD cyclers and
equipment, which include special safety
features such as automatic bag connection
and highly intuitive, easy-to-understand
design. Such elements offer advanced
protection from infections as well as from
incorrect handling, which is especially
important as many patients undergo treatment
at home.'Preserve' alludes to the Company's
PD fluids, which, due to their physiological
pH and low amount of glucose degradation
products, contribute particularly well to
the preservation of a patient's peritoneal
membrane and residual renal functions. 'Prolong',
finally, refers to the aim of 'P3' to
prolong high-quality treatment outcomes, for
example through complementary therapies for
the control of a patient's body fluid
balance or special monitoring software to
individually adjust and optimize a patient's
treatment parameters.
"It is Fresenius Medical Care's mission to
deliver excellent care to patients through
innovative programs, the latest technology,
continuous improvement and a focus on
superior customer service. 'P3' is a further
step on this mission, helping our PD
patients to be more successful on dialysis
so they can live their lives to the fullest",
says Dr. Teresa Portela, Marketing Director
Home Therapies at Fresenius Medical Care.
In peritoneal dialysis, or PD, the patient's
peritoneum is used as the dialyzing membrane.
A sterile dialysis solution is introduced
and discharged through a catheter that has
been surgically implanted into the patient's
abdominal cavity. The solution removes
toxins along with excess water. The patient
administers the treatments several times a
day or during the night supported by a
machine, the cycler.
Source:
www.fmc-ag.com
|
